Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metrizamide compared with iohexol for cervical myelography: a double-blind study.

R Reisin1, R Ethier, V de la Sayette

  • 1Department of Radiology, Montreal Neurological Hospital & Institute, Quebec.

Canadian Association of Radiologists Journal = Journal L'Association Canadienne Des Radiologistes
|June 1, 1988
PubMed
Summary

Iohexol is a safer alternative to metrizamide for cervical myelography, showing significantly fewer adverse effects like nausea and vomiting. This comparative study highlights iohexol

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissipative Landau-Zener tunneling in the crossover regime from weak to strong environment coupling.

Nature communications·2025
Same author

Ultra-high dose of intravenous immunoglobulin restores strength and motor function in a patient with refractory multifocal motor neuropathy.

Revista de neurologia·2023
Same author

Non-convulsive status epilepticus as the initial manifestation in a family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Neurologia·2022
Same author

Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports.

Revista de neurologia·2021
Same author

Non-convulsive status epilepticus as the initial manifestation in a family with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Neurologia·2020
Same author

[Trident sign in spinal cord neurosarcoidosis].

Revista de neurologia·2020

Area of Science:

  • Radiology and Imaging
  • Neurology
  • Pharmacology

Background:

  • Cervical myelography is a diagnostic procedure used to visualize the spinal cord.
  • Iohexol and metrizamide are contrast agents used in myelography.
  • Assessing the safety and efficacy of different contrast agents is crucial for patient care.

Purpose of the Study:

  • To compare the safety and efficacy of iohexol versus metrizamide for cervical myelography.
  • To evaluate radiographic and computed tomographic (CT) imaging quality.
  • To assess the incidence and severity of adverse events associated with each contrast agent.

Main Methods:

  • A double-blind, comparative study involving 30 patients undergoing cervical myelography via lumbar puncture.
  • Patients were randomized to receive either iohexol or metrizamide.

Related Experiment Videos

  • Radiographic and postmyelographic CT scans of the cervical spine were analyzed for image quality.

    • Main Results:

    • No significant difference in radiographic or CT image quality was observed between iohexol and metrizamide.
    • The overall incidence of side effects was significantly higher with metrizamide (93.4%) compared to iohexol (40%).
    • Nausea, vomiting, pyramidal signs, and seizures were significantly more frequent in the metrizamide group.

    Conclusions:

    • Iohexol demonstrates a significantly better safety profile than metrizamide for cervical myelography.
    • Iohexol provides comparable image quality to metrizamide.
    • Iohexol is recommended as a preferred contrast agent for cervical myelography due to reduced adverse events.